课题基金 / 基金详情

Development of fluorogenic and chemiluminogenic main protease substrates for cellular and in vivo imaging of SARS-CoV-2

Development of fluorogenic and chemiluminogenic main protease substrates for cellular and in vivo imaging of SARS-CoV-2
开发用于 SARS-CoV-2 细胞和体内成像的荧光和化学发光主要蛋白酶底物
批准号:
10611456
负责人:
Wenshe Ray Liu
金额:
$18.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-01 至 2025-02-28

项目摘要

项目成果

Wenshe Ray Liu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY COVID-19 is the currently prevailing pandemic that has paralyzed much of the world. The viral pathogen of COVID-19 is SARS-CoV-2, a coronavirus with a positive sense RNA genome. Its production in the human cell host requires the activity of its main protease (MPro). As a unique enzyme that is essential to SARS-CoV-2, MPro is acutely toxic to the host cell indicating that it is tightly regulated during viral infection and replication. Its activity also represents active viral reproduction in organs and tissues in an infected host organism. Therefore, the detection of MPro activity in SARS-CoV-2-infected cells and animals will provide essential information about MPro activity regulation in the host cell and SARS-CoV-2 spreading and distribution in a host organism respectively for the elucidation of SARS-CoV-2 replication and pathogenesis. Noninvasive imaging reagents will be critical for the detection of MPro activity in order to avoid interference with both the virus and the host. With an ultimate goal of understanding the SARS-CoV-2 replication in infected cells and elucidating SARS-CoV-2 spreading patterns and organ/tissue distribution in infected animals, the current proposal aims to develop noninvasive fluorogenic and chemiluminogenic MPro substrates that have highly cellular stability and tissue penetrability for imaging MPro activity. Three specific aims will be pursued by 1) developing fluorogenic and chemiluminogenic MPro substrates; 2) characterizing fluorogenic and chemiluminogenic MPro substrates on their selectivity, cellular stability and tissue penetrability; and 3) conducting cellular and in vivo imaging of SARS-CoV-2 infection. The successful completion of the proposed study will 1) result in fluorogenic and chemiluminogenic MPro substrates with optimal cellular stability and tissue penetratability that can be broadly adopted by COVID-19 researchers for the investigation of SARS-CoV-2 replication and pathogenesis and 2) provide critical information for the elucidation of Mpro activity regulation in SARS-CoV-2-infected cells and SARS-CoV-2 spreading patterns and distribution in transgenic hACE2+ mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of fluorogenic and chemiluminogenic main protease substrates for cellular and in vivo imaging of SARS-CoV-2
  • 批准号:
    10432895
  • 项目类别:
  • 资助金额:
    $22.46万
  • 财政年份:
    2022
  • 负责人:
    Wenshe Ray Liu
  • 依托单位:
Use of the Noncanonical Amino Acid Mutagenesis Technique in Combination with Other Approaches to Study Functions of Posttranslational Lysine Modifications in Proteins
  • 批准号:
    10406602
  • 项目类别:
  • 资助金额:
    $31.04万
  • 财政年份:
    2022
  • 负责人:
    Wenshe Ray Liu
  • 依托单位:
Use of the Noncanonical Amino Acid Mutagenesis Technique in Combination with Other Approaches to Study Functions of Posttranslational Lysine Modifications in Proteins
  • 批准号:
    10591531
  • 项目类别:
  • 资助金额:
    $51.94万
  • 财政年份:
    2022
  • 负责人:
    Wenshe Ray Liu
  • 依托单位:
Targeting the ENL YEATS domain for the development of anti-leukemia agents
  • 批准号:
    10357052
  • 项目类别:
  • 资助金额:
    $20.75万
  • 财政年份:
    2021
  • 负责人:
    Wenshe Ray Liu
  • 依托单位:
海外基金